Triglyceride is the major atherogenic lipid in NIDDM

Diabetes/Metabolism Reviews

Volumn 13, Issue 2, 1997, Pages 93-98

  Taskinen, Marja Riitta ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; DYSLIPIDEMIA; HUMAN; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; HUMANS; TRIGLYCERIDES;

EID: 0030811072     PISSN: 07424221     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0895(199706)13:2<93::AID-DMR187>3.0.CO;2-6     Document Type: Review

References (31)

1. Pyörälä K, Laakso M, and Uusitupa K: Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 3: 463-524, 1987.
2. Bierman EL: Atherogenesis in diabetes. Arterioscler Thromb 12: 647-656, 1992.
3. Stamler J, Vaccaro O, Neaton JD, and Wentworth D: Diabetes, other risk factors, and 12 year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 16: 434-444, 1993.
4. Howard BV: Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28: 613-628, 1987.
5. Taskinen M-R: Hyperlipidaemia in diabetes. Baillière's Clin Endocrinol Metab 4: 743-775, 1990.
6. Stern MP, and Haffner SM: Dyslipidaemia in type II diabetes: implications for therapeutic intervention. Diabetes Care 14: 1144-1159, 1991.
7. Taskinen M-R: Diabetic dyslipidaemia in NIDDM. Int Diabetes Monitor 8 (2): 1-7, 1996.
8. Assmann G, and Schulte H: The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidaemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 116: 1713-1724, 1988.
9. Lahdenperä S, Syvänne M, Kahri J, and Taskinen M-R: Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides. Diabetologia 39: 453-461, 1996.
10. Fontbonne A, Eschwege E, Cambien F, Richard JL, Ducimetiere P, Thibult N, Warnet J-M, Claude J-R, and Rousselin G-E: Hypertriglyceridaemia as a risk factor for coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32: 300-304, 1989.
11. Laakso M, Lehto S, Penttilä I, and Pyörälä K: Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 88: 1421-1430, 1993.
12. Hanefeld M, Fischer S, Julius U, Schutze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, and Lindner J: Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39: 1577-1583, 1996.
13. Grundy SM, and Vega GL: Two different views of the relationship of hypertriglyceridaemia to coronary heart disease: implications for treatment. Arch Intern Med 152: 28-34, 1992.
14. Karpe F, and Hamsten A: Postprandial lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol 6: 123-129, 1995.
15. Cohn JS: Postprandial lipid metabolism. Curr Opin Lipidol 5: 185-190, 1994.
16. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, and Krauss RM: Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260: 1917-1921, 1988.
17. Austin MA, King M-C, Vranizan KM, and Krauss RM: Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation 82: 495-506, 1990.
18. Krauss RM: Heterogeneity of plasma low-density lipoproteins and atherosclerotic risk. Curr Opin Lipidol 5: 339-349, 1994.
19. Lyons TJ: Lipoprotein glycation and its metabolic consequences. Diabetes 41 (Suppl. 2): 67-73, 1992.
20. Ebenbichler CF, Kirchmair R, Egger C, and Patsch JR: Postprandial state and atherosclerosis. Curr Opin Lipidol 6: 286-290, 1995.
21. Patsch JR, Meisenböck G, Hopferwieser T, Mühlberger V, Knapp E, Dunn JK, Gotto AM Jr, and Patsch W: Relation of triglyceride metabolism and coronary heart diseaes, studies in the postprandial state. Arterioscler Thromb 12: 1336-1345, 1992.
22. Simpson HS, Williamson CM, Olivecrona T, Pringle J, Maclean J, Lorimar AR, Bonnefous F, Bogaievsky Y, Packard CJ, and Shepherd J: Post-prandial lipaemia, fenofibrate and coronary artery disease. Atherosclerosis 85: 193-202, 1990.
23. Karpe F, Steiner G, Uffelman K, Olivecrona T, and Hamsten A: Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 106: 83-97, 1994.
24. Lewis GF, O'Meara NM, Soltys PA, Blackman JD, Iverius PH, Pugh WL, Gestz GS, and Polonsky KS: Fasting hypertriglyceridaemia in non-insulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab 72: 934-944, 1991.
25. Chen Y-D, and Reaven GM: Intestinally derived lipoproteins: metabolism and clinical significance. Diabetes Metab Rev 7: 191-208, 1991.
26. Syvänne M, Hilden H, and Taskinen M-R: Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary heart disease. J Lipid Res 35: 15-26, 1994.
27. Cummings MH, Watts GF, Umpleby AM, Hennessy TR, Naoumora R, Slavin BM, Thompson CR, and Sonksen PH. Increased hepatic secretion of very low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetologia 38: 959-967, 1995.
28. Stewart MW, Laker MF, Dyer RG, Game F, Mitcheson J, Winocour PH, and Alberti KG: Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidaemia. Arterioscler Thromb 13: 1046-1052, 1993.
29. Golay A, Zech L, Shi M-Z, Chiou Y-AM, Reaven GM, and Chen Y-DI: High density lipoprotein (HDL) metabolism in non-insulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL. J Clin Endocrinol Metabl 65: 512-518, 1987.
30. Koskinen P, Mänttäri M, Manninen V, Huttunen JK, Heinonen OP, and Frick MH: Coronary heart disease incidence in NIDDM patients in the Helsinki heart study. Diabetes Care 15: 820-825, 1992.
31. Steinberg D. The cholesterol controversy is over. Why did it take so long? Circulation 80: 1070-1078, 1989.